Searched for
BIBCOL
Over 550 scientists returned to India to pursue research in biotechnology: CentreThe Ramalingaswami Re-entry Fellowship is a prestigious scheme of the Department of Biotechnology, which was launched in 2006-07 with the a...- Hester Biosciences to roll out Covaxin drug substance by April 2022Ahmedabad-based Hester Biosciences is a part of Gujarat Covid Vaccine Consortium (GCVC), which in May this year signed an agreement with Bh...
- Two vax makers, who signed up to produce Covaxin, may not roll out supplies till 2022 Q2Haffkine, owned by the Maharashtra government, and BIBCOL entered licensing agreements with Bharat Biotech to produce a Covaxin drug substa...
- Monthly production capacity of Covishield, Covaxin planned to be increased: GovtFrom January 16 to August 5, 44.42 crore doses of Covishield were supplied by Serum Institute of India and 6.82 crore doses of Covaxin by B...
- IIL may start supplying 20 lakh doses of Covaxin by September: GovtOn the production plan of Covaxin at various facilities, NITI Aayog member (Health) Dr V K Paul said there were some initial hiccups relate...
- Monthly production capacity of Covishield projected to increase to 120 million doses, Covaxin to 58 million doses: MinisterUnion Health Minister Mansukh Mandaviya was responding to a question on the current capacity to manufacture Covaxin and Covishield in the c...
- State-owned BIBCOL set to begin production of Bharat Bio's Covaxin by February 2022The government is now betting on Indian Immunologicals to boost Covaxin production this year as Haffkine Bio-Pharma managing director Sande...
- Only marginal difference in purchase price of Covishield, Covaxin for Centre: MoS HealthIn fact, the Government of India has been supplying vaccines free of cost to the states/UTs for administration to prioritised beneficiaries...
- Supply enough, 200-220 million vaccine doses from July: NK AroraIndia vaccinated more than 8 million people on Monday, which marked the start of a new inoculation regime. It was the country’s highest sin...
- Covaxin output may hit 100 million doses per month by November“For Covaxin, we will see a significant (production) ramp-up of more than double in August-September, when the doses manufactured by Bharat...
- What pharma PSUs and government vaccine makers can and cannot do in the uphill battle against CovidWhile government-owned pharma companies are ailing from years of neglect, some have rolled up their sleeves and joined India’s uphill battl...
- Government exploring possibility of Covaxin production outside IndiaThe government also intends to take up the matter with the World Health Organisation (WHO) to step up Covaxin production.
- Bharat Biotech raises Covaxin capacity by another 200 million doses a year“The company plans to produce 200 million doses of Covaxin per annum in the GMP facilities that are already operational for the production ...
- Gujarat govt in talks with Bharat Biotech to ramp up production of Covaxin: DBT"Further, Gujarat Biotechnology Research Centre, Department of Science and Technology Govt of Gujarat along with Hester Biosciences and Omn...
- Reports of delay in licensing for Covaxin 'factually incorrect': Govt"There have been reports in a section of the media followed by some uninformed tweets alleging delay in licensing for Covaxin and delayed a...
- Govt aims for 6-7 crore Covaxin doses/month by July-AugustThe state-run Public Sector Undertaking (PSUs) will manufacture the drug on the basis of transfer of technology. “The government of India w...
- Centre approved anti-viral medicines to treat COVID-19 patients, says SCThe top court was hearing a plea seeking registration of an FIR by the CBI against ten Indian pharmaceutical firms for manufacturing and se...
- 250% rally amid lockdown. Beware! Rumours driving up this microcap stockThe company has a free float market-cap of about Rs 33.55 crore as of Wednesday.
- India will be self-reliant in producing RT-PCR testing kits by May-end: VardhanOut of at least half a dozen candidates (companies) supported for vaccines, four are in an advanced stage and regulatory platform at one pl...
Load More
